Terug
Ook genoteerd als
DRPRF
OTC
Dagbereik
€ 4,25
€ 4,37
52-Weeksbereik
€ 4,11
€ 5,66
Volume
25.647
50D / 200D Gem.
€ 4,73
/
€ 5,00
Vorige Slotkoers
€ 4,36
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Consumer Cyclical sector mediaan (610 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 93,0 | 11,1 |
| P/B | 1,7 | 1,4 |
| ROE % | 1,9 | 10,7 |
| Net Margin % | 1,2 | 5,2 |
| Rev Growth 5Y % | 2,3 | 8,1 |
| D/E | 0,5 | 0,8 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,47
€ 0,44 – € 0,49
|
46,15B | 1 |
| FY2029 |
€ 0,39
€ 0,36 – € 0,41
|
44,09B | 1 |
| FY2028 |
€ 0,33
€ 0,31 – € 0,35
|
44,25B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-11 | € 0,04 | € 0,04 | -11,3% |
| 2025-10-24 | -€ 0,13 | -€ 0,08 | +40,5% |
| 2025-07-30 | € 0,06 | € 0,03 | -53,6% |
| 2025-04-29 | N/A | € 0,61 | — |
| 2025-02-06 | N/A | € 0,94 | — |
| 2024-10-25 | € 0,13 | € 0,74 | +489,9% |
| 2024-07-24 | N/A | € 1,10 | — |
| 2024-06-29 | N/A | € 1,45 | — |
Dividend History
3 yr streakYield
0,05%
Payout Ratio
4,87%
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| May 23, 2025 | Jun 10, 2025 | € 0,26 | 5,47% |
| Jun 11, 2024 | Jun 27, 2024 | € 0,20 | 2,54% |
| Jun 29, 2023 | Jul 18, 2023 | € 0,09 | 0,72% |
Belangrijkste Punten
Revenue grew 2,28% annually over 5 years — modest growth
Earnings declined -88,00% over the past year
ROE of 1,87% is below average
Debt/Equity of 0,49 — conservative balance sheet
Generating 3,61B in free cash flow
P/E of 92,99 — premium valuation
Groei
Revenue Growth (5Y)
2,28%
Revenue (1Y)-9,51%
Earnings (1Y)-88,00%
FCF Growth (3Y)11,14%
Kwaliteit
Return on Equity
1,87%
ROIC0,90%
Net Margin1,19%
Op. Margin1,14%
Veiligheid
Debt / Equity
0,49
Current Ratio1,41
Interest Coverage2,44
Waardering
P/E Ratio
92,99
Forward P/E21,28
P/B Ratio1,74
EV/EBITDA112,47
Dividend Yield0,05%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -9,51% | Revenue Growth (3Y) | -5,40% |
| Earnings Growth (1Y) | -88,00% | Earnings Growth (3Y) | -71,09% |
| Revenue Growth (5Y) | 2,28% | Earnings Growth (5Y) | -42,82% |
| Profitability | |||
| Revenue (TTM) | 36,27B | Net Income (TTM) | 431,00M |
| ROE | 1,87% | ROA | 0,82% |
| Gross Margin | 13,93% | Operating Margin | 1,14% |
| Net Margin | 1,19% | Free Cash Flow (TTM) | 3,61B |
| ROIC | 0,90% | FCF Growth (3Y) | 11,14% |
| Safety | |||
| Debt / Equity | 0,49 | Current Ratio | 1,41 |
| Interest Coverage | 2,44 | ||
| Dividends | |||
| Dividend Yield | 0,05% | Payout Ratio | 4,87% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 3 yrs | ||
| Valuation | |||
| P/E Ratio | 92,99 | Forward P/E | 21,28 |
| P/B Ratio | 1,74 | P/S Ratio | 1,10 |
| PEG Ratio | -1,08 | Forward PEG | N/A |
| EV/EBITDA | 112,47 | Fwd EV/EBITDA | 4,66 |
| Forward P/S | 0,98 | Fwd Earnings Yield | 4,70% |
| FCF Yield | 9,02% | ||
| Market Cap | 40,08B | Enterprise Value | 46,45B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 36,27B | 40,08B | 40,53B | 37,63B | 33,14B |
| Net Income | 431,00M | 3,59B | 5,16B | 4,96B | 4,03B |
| EPS (Diluted) | 0,05 | 0,40 | 0,57 | 0,55 | 0,44 |
| Gross Profit | 5,05B | 10,33B | 11,77B | 10,69B | 8,99B |
| Operating Income | 413,00M | 5,64B | 7,28B | 7,25B | 5,61B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 52,72B | 53,53B | 50,45B | 47,67B | 51,38B |
| Total Liabilities | 29,59B | 30,47B | 28,78B | 30,65B | 28,45B |
| Shareholders' Equity | 22,99B | 23,04B | 21,67B | 13,30B | 9,19B |
| Total Debt | 11,37B | 11,33B | 10,36B | 9,48B | 9,72B |
| Cash & Equivalents | 5,00B | 6,38B | 5,82B | 3,72B | 4,69B |
| Current Assets | 19,94B | 20,29B | 20,04B | 20,19B | 18,55B |
| Current Liabilities | 14,12B | 14,34B | 13,57B | 16,61B | 13,08B |
